Skip to main content icon/video/no-internet

Test of Memory Malingering (TOMM)

The issue of malingering is becoming increasingly important in the field of forensic psychology, particularly in cases involving traumatic brain injury, where alleged memory impairment is often used to seek personal compensation or as a defense against prosecution for various types of crimes. The Test of Memory Malingering (TOMM) was developed by the author to provide an objective, criterion-based test that is able to discriminate between individuals with bona fide memory impairment and those with feigned symptoms of impaired memory. The acronym TOMM was selected to emphasize that the test was developed with a definite, preconceived notion—to determine whether or not an individual is feigning or malingering a memory impairment. Thus, the TOMM should not be viewed as a malingering test per se.

The TOMM consists of two learning trials and a retention trial. The learning trials consist of a learning phase and a test phase. The study portion of each learning trial contains 50 line-drawn pictures (targets), each presented for 3 seconds with a 1-second interval between pictures. The same 50 pictures are used on each learning trial. However, they are presented in a different order on the second trial. During the test phase, each target is paired with a new line drawing (distractor). The position of the target is counterbalanced for the top and bottom positions. The person is required to select the correct picture (i.e., target) from each panel. For each answer, the examiner provides feedback about the correctness of the response. A delayed retention trial, consisting only of the test phase, is administered approximately 15 to 20 minutes after completion of the two learning trials. The TOMM is available in a computerized as well as a paper-and-pencil format.

Development and Validation

The TOMM was initially validated with 475 communitydwelling adults ranging in age from 17 to 84 years and 187 neuropsychological assessments from patients classified as follows: no cognitive impairment (n = 13), cognitive impairment (n = 42), aphasia (n = 21), traumatic brain injury (TBI) (n = 45), depression (n = 26), and dementia (n = 40). Inspection of the distribution of correct responses for the cognitively intact participants and the clinical patients showed that most nondemented individuals achieved a perfect score on Trial 2 and the retention trial. Moreover, rarely did a nondemented patient obtain a score lower than 45. In view of these results, the criterion score of 45 on Trial 2 or on the retention trial was selected. That is, any score lower than 45 should raise concern that an individual is not putting forth the maximum effort and is likely malingering. The criterion score correctly classified 100% of the communitydwelling participants and 95% of the nondemented clinical patients (cognitively impaired = 90%; aphasia = 95%; TBI = 98%; depressed = 100%; and dementia = 73%). Thus, the only clinical sample with a relatively low sensitivity score was the dementia group. Even these individuals still obtained a score of greater than 92% on Trial 2. The finding that the scores on the TOMM were less than 95% for the dementia group is not particularly negative since it is unlikely that feigning memory impairment is a major issue when dementia patients undergo neuropsychological assessment.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading